Rising Demand Drives Pain Management Devices Market Expansion The Pain Management Devices Market has emerged as a critical segment within the global healthcare industry, addressing the growing need ...

Global Disposable Endoscopes Market OutlookThe global disposable endoscopes market is set to experience robust growth, with a projected compound annual growth rate (CAGR) of around 13% over the ...

The global Sepsis Diagnostics Market is projected to grow steadily at an annual rate of around 7% over the next five years, ...

Global Sterilization Services Market OverviewThe global sterilization services market is projected to experience steady ...

UPPSALA, SE / ACCESS Newswire / April 20, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has expanded its agreements with a leading hospital system (IDN) with network in ...

LUND, SE / ACCESS Newswire / April 20, 2026 / Alligator Bioscience (STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today announced that ...

Genflow Biosciences Enters Strategic Technology Collaboration with Acuitas Therapeutics - Fully Funded, Non-Dilutive Access to World-Class LNP Delivery Platform LONDON, UK / ACCESS Newswire / April 20 ...

The Best Deep Plane Facelift is done by Dr. Alberico Sessa in Florida SARASOTA, FL / ACCESS Newswire / April 20, 2026 / Interest in advanced facial rejuvenation continues to grow as patients are ...

A 4/20 Message From MMJ Leadership"April 20 has always been a day about access," said Duane Boise, President & CEO of MMJ International Holdings."Now it needs to become a day about standards.

SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced ...

Insights derived from one of the largest datasets with over 250 million harmonized variant calls from over 8,000 tumor-normal ...

The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of checkpoint inhibitor refractory unresectable or metastatic melanoma with PD-L1+ ...